genetics experience summary nr.110.521a- cns ii july, 2013 tania randell, rn-bc, bsn

7
Genetics Experience Summary NR.110.521A- CNS II July, 2013 Tania Randell, RN-BC, BSN

Upload: edmund-copeland

Post on 14-Jan-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Genetics Experience Summary NR.110.521A- CNS II July, 2013 Tania Randell, RN-BC, BSN

Genetics Experience

Summary

NR.110.521A- CNS IIJuly, 2013Tania Randell, RN-BC, BSN

Page 2: Genetics Experience Summary NR.110.521A- CNS II July, 2013 Tania Randell, RN-BC, BSN

Location & Focus 

Johns Hopkins Outpatient Center Cardiology Clinic

Genetic Counselor sees patients with various types of structural Cardiomyopathy (CM)

ARVD Dilated Hypertrophic Restrictive Non-compaction Amyloid

Page 3: Genetics Experience Summary NR.110.521A- CNS II July, 2013 Tania Randell, RN-BC, BSN

Typical Patients

Patients are referred by their Cardiologist who specializes in Cardiomyopathy

Genetic counselor works for this physician

If interested- Initial phone call Pedigree is done by email Initial interview & description of testing If patient agrees to Pan CM Panel, they return for

explanation of results

Page 4: Genetics Experience Summary NR.110.521A- CNS II July, 2013 Tania Randell, RN-BC, BSN

Case Study

34 y/o AA Female diagnosed w/ Dilated CM @ 29

Pregnant with twins (induce 12 wks early)

10 siblings, Sister w/ CM

Other relatives- disease processes and deaths that are now questionable (strokes, “accident”)

Babies have 50% chance of developing CM

Testing only 20-30% chance of getting a definitive explanation for the CM

Page 5: Genetics Experience Summary NR.110.521A- CNS II July, 2013 Tania Randell, RN-BC, BSN

Implications for APNs

Baseline knowledge of genetic testing

Referral information

Who is appropriate for referral

Collaborate w/ MDs

Page 6: Genetics Experience Summary NR.110.521A- CNS II July, 2013 Tania Randell, RN-BC, BSN

     Insights…

Races other than Caucasian and African American have a small pool (need more participants-what’s normal for their group)

Even when mutations are identified, only handful of results change treatment (ICD, frequent Echoes)

Most people do testing to help their families

Families w/ a great deal of disease are best to study (can find links between their genes)

Return yearly (science is developing rapidly)

Page 7: Genetics Experience Summary NR.110.521A- CNS II July, 2013 Tania Randell, RN-BC, BSN

Reference

Baxter S., Cirino, A, Funke, B., Ho, C., Hernandez A.L., Rehm,H., Seidman, C., & Seidman, J. (2013). Genetic Basis of Cardiomyopathy: A Guide for Patients and Families. Harvard Medical School Laboratory for Molecular Medicine, Cambridge, MA.